Internal Medicine · Uniontown, OH
NPI
1215015870
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3838 Massillon Rd
Uniontown, OH, 44685
Phone (330) 896-9625
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
68,151 services
Medicare patients, 2024
88
Average age 63
Drug cost, 2024
$3.7M
2,556 prescriptions
Company payments, 2025
$1,591
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy J Carrabine was code J2323 (injection, natalizumab, 1 mg), 44,707 times for 15 patients. In total Timothy J Carrabine billed 68,151 services in 11 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2323 Injection, natalizumab, 1 mg | Office | 44,707 | 15 | $17.13 | $766K |
| J2350 Injection, ocrelizumab, 1 mg | Office | 22,804 | 26 | $44.61 | $1.0M |
| 96415 Chemotherapy Administration | Office | 159 | 29 | $18.34 | $2,916 |
| 96413 Chemotherapy Administration | Office | 128 | 44 | $82.32 | $11K |
| 99214 Office E&M - Established | Office | 92 | 73 | $76.10 | $7,001 |
| 96365 Intravenous Infusion, Hydration | Office | 87 | 13 | $44.89 | $3,905 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 56 | 26 | $0.23 | $12.61 |
| 96375 Injection Administration | Office | 53 | 29 | $10.12 | $537 |
| J2930 Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 49 | 17 | $4.52 | $221 |
| 99213 Office E&M - Established | Office | 13 | 12 | $58.68 | $763 |
By year: 2022 $1.8M for 74,199 services; 2023 $1.8M for 71,227 services; 2024 $1.8M for 68,151 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy J Carrabine prescribed most often to Medicare patients was Baclofen, with 404 prescriptions and refills. In total Timothy J Carrabine wrote 2,556 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 404 | 633 | 88 | $7,695 |
| Gabapentin Generic | 215 | 409 | 48 | $5,681 |
| Tizanidine Hcl Generic | 144 | 238 | 34 | $1,430 |
| Kesimpta Pen Ofatumumab | 120 | 122 | 19 | $1.1M |
| Clonazepam Generic | 119 | 136 | 27 | $536 |
| Copaxone Glatiramer Acetate | 104 | 110 | 11 | $609K |
| Glatiramer Acetate Generic | 91 | 98 | 14 | $215K |
| Teriflunomide Generic | 83 | 91 | 12 | $220K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 74 | 74 | 14 | $2,021 |
| Duloxetine Hcl Generic | 54 | 90 | 11 | $848 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 52 | 56 | Under 11 | $462K |
| Tramadol Hcl Generic | 51 | 51 | Under 11 | $330 |
| Dalfampridine Er Dalfampridine | 51 | 63 | 12 | $28K |
| Lorazepam Generic | 44 | 50 | 12 | $159 |
| Ropinirole Hcl Generic | 40 | 86 | Under 11 | $463 |
Brand drugs: - claims; generic drugs: 2,122 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy J Carrabine $1,591 ($1,591 in general payments such as food, travel and fees) from 12 companies. The largest payer was TG Therapeutics, Inc. with $397.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 8 | $397 |
| Biogen, Inc. BIIB | 13 | $374 |
| EMD Serono, Inc. MRK.DE | 10 | $227 |
| Celgene Corporation BMY | 14 | $148 |
| Cycle Pharmaceuticals Inc | 5 | $85.98 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $79.35 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $71.31 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $70.76 |
| Genentech USA, Inc. ROG.SW | 3 | $68.35 |
| Genzyme Corporation SNY | 2 | $39.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.